[Treatment of oligometastatic or oligoprogression cancer]

Cancer Radiother. 2019 Oct;23(6-7):482-485. doi: 10.1016/j.canrad.2019.07.143. Epub 2019 Sep 5.
[Article in French]

Abstract

We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival, and to identify the place of SBRT in patient's pathway.

Keywords: Oligometastases; Oligométastases; Radiothérapie stéréotaxique; Stereotactic radiotherapy.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / pathology
  • Breast Neoplasms / radiotherapy*
  • Cancer Survivors
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / radiotherapy*
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Disease Progression
  • Female
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Male
  • Neoplasm Metastasis
  • Prognosis
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Radiosurgery / methods*
  • Randomized Controlled Trials as Topic